Medprin Regenerative Medical Technologies Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 32.80% vs 14.64% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 40.20% vs 51.11% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.50",
          "val2": "68.90",
          "chgp": "32.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.40",
          "val2": "27.50",
          "chgp": "6.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.60",
          "val2": "20.40",
          "chgp": "40.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "321.10%",
          "val2": "297.90%",
          "chgp": "2.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.66% vs 17.42% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "275.70",
          "val2": "228.50",
          "chgp": "20.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "102.50",
          "val2": "68.60",
          "chgp": "49.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "2.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.10",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.90",
          "val2": "40.90",
          "chgp": "92.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.60%",
          "val2": "183.90%",
          "chgp": "8.67%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

91.50

68.90

32.80%

Operating Profit (PBDIT) excl Other Income

29.40

27.50

6.91%

Interest

0.00

0.00

Exceptional Items

0.30

0.00

Consolidate Net Profit

28.60

20.40

40.20%

Operating Profit Margin (Excl OI)

321.10%

297.90%

2.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 32.80% vs 14.64% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 40.20% vs 51.11% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

275.70

228.50

20.66%

Operating Profit (PBDIT) excl Other Income

102.50

68.60

49.42%

Interest

1.20

2.40

-50.00%

Exceptional Items

-0.30

0.10

-400.00%

Consolidate Net Profit

78.90

40.90

92.91%

Operating Profit Margin (Excl OI)

270.60%

183.90%

8.67%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 20.66% vs 17.42% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023

All Annual Results